Showing results (771-780 of 4,872) with videos related to
Sort By:
Pageof 488
Urologic Oncology|July 17, 2014
Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristicsSelcuk Erdem, Akin Soner Amasyali, Omer Aytac, et al.Urologic Oncology|July 30, 2014
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinomaDaniele Minardi, Matteo Santoni, Guendalina Lucarini, et al.Urologic Oncology|August 2, 2014
Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysisHaichao Yuan, Xiaofan Chen, Liangren Liu, et al.Urologic Oncology|August 5, 2014
Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005Scott EggenerUrologic Oncology|May 4, 2012
The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community settingYuanyuan Liang, Donna P Ankerst, Ziding Feng, et al.Urologic Oncology|June 13, 2012
PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experienceChristian G Ramos, Raul Valdevenito, Ivonne Vergara, et al.Urologic Oncology|June 13, 2012
Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: practice patterns of uro-oncologists in North AmericaKarim A Touijer, Youness Ahallal, Bertrand D GuillonneauUrologic Oncology|September 17, 2013
Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: a reviewTimothy A Masterson, Kevin R Rice, Stephen D W BeckPageof 488